Bullish outlook for T-Slim X2 Basal-IQ tech

Sep 4, 2018

TNDM was once a $300 stock, struggled on sales and debt. At the time, they did not have the supreme product and it crashed. Compare to PODD Omnipod that only has bolus and you have to manually suspend, you would want to be with t-slim if you are a diabetic patient. T-slim x2 is marketed globally, sales are up on Q2. Expecting a BIG Q3 from these guys. Pullback? Maybe a little, maybe later, but it's definitely not too late to get in, it's too hot right now. PT $80

+279% 200SMA, +54% 50SMA, +27% 20SMA, Are you sure that you want to be on the other side of the trade?

Dec 4, 2018

Trade closed: target reached

Jan 12, 2019

Trade active